ArticleComputational and structural biotechnology journal2021

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types.

Szu-Yuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.